![]() ViewPoint Therapeutics ViewPoint Therapeutics is a biotechnology company which develops treatments for diseases of protein misfolding, including cataracts. | ![]() Molecular Partners Molecular Partners is a company that develops biopharmaceutical products for serious diseases. | ![]() Brii Biosciences Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses. | ![]() Prevail Therapeutics Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease. | |
Founding Date | Founding Date 2014 | Founding Date 2004 | Founding Date 2018 | Founding Date 2017 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations San Mateo, US HQ San Francisco, US | Locations Zürich-Schlieren, CH HQ Cambridge, US Concord, US | Locations CN HQ Beijing, CN Durham, US San Francisco, US San Mateo, US | Locations New York, US HQ |
Employees | Employees 1 | Employees 158 | Employees 8510% decrease | Employees 489% increase |
Financial | ||||
Net income | Net income N/A | Net income (CHF61.7m) (FY, 2025) | Net income N/A | Net income ($63.2m) (FY, 2019) |
Funding | ||||
Latest funding round | Latest funding round $ 35m (over 8 years ago) | Latest funding round N/A | Latest funding round $ 155m (over 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 39m | Total funding raised N/A | Total funding raised $ 415m | Total funding raised $ 125m |

Molecular Partners is a company that develops biopharmaceutical products for serious diseases.
View company
Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses.
View company
Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease.
View company